Research theme for competitive and other funds (7):
2017 - 2020 全身性強皮症におけるEffector B細胞の役割について検討
1987 - 細胞成長因子
1987 - 抗核抗体
1987 - 強皮症
1987 - Growth factor
1987 - Antinuclear antibody
1987 - Scleroderma
Show all
Papers (30):
Miyu Kano, Tadahiro Kobayashi, Mutsumi Date, Momoko Tennichi, Yasuhito Hamaguchi, Daniel S. Strasser, Kazuhiko Takehara, Takashi Matsushita. Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod. Scientific Reports. 2019. 9. 1. 658
Kyoko Shimizu, Takashi Matsushita, Kazuhiko Takehara, Yasuhito Hamaguchi. A case of juvenile localized scleroderma with anti-topoisomerase I antibody. European Journal of Dermatology. 2019. 29. 4. 443-444
Kie Mizumaki, Shintaro Maeda, Yuka Ikawa, Takashi Matsushita, Kazuhiko Takehara, Yasuhito Hamaguchi. A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy. Journal of Dermatology. 2019. 46. 7. e251-e253
Natsuki Yagi-Numata, Takashi Matsushita, Kazuhiko Takehara, Yasuhito Hamaguchi. Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis. Clinical and experimental rheumatology. 2019. 37. 4. 23-31